Marcell Costa de Medeiros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marcell Costa de Medeiros has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Rossa
Department of Diagnosis and Surgery, School of Dentistry at Araraquara, São Paulo State University (UNESP), Araraquara, Brazil
9 shared publications - Giovana Anovazzi
Universidade Estadual Paulista, Brasil
4 shared publications - Nisha J. D'SIlva
Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, USA
4 shared publications - Raquel Mantuaneli Scarel Caminaga
Department of Morphology, Genetics, Orthodontics and Pediatric Dentistry, School of Dentistry at Araraquara, São Paulo State University—UNESP, Araraquara 14801-903, SP, Brazil
4 shared publications Min Liu
University of Michigan
3 shared publications- Suzane Cristina Pigossi
Federal University of Uberlândia, Brazil
3 shared publications
Latest Publications
- Open Access
Splicing of HPV16 E6 promotes aggressive invasion in oropharyngeal cancer via endocytosis of E-cadherin
Human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC) is now the leading HPV+ cancer in the United States and United Kingdom. Despite high cure rates, a significant subset of patients have aggressive HPV+ OPSCC that recurs; deciphering the underlying mechanisms will identify biomarkers that delineate patient subgroups for personalized treatment. In a comprehensive investigation using complementary clinically-relevant models of HPV+ OPSCC, we demonstrated that elevated expression of a HPV16 E6 spliced isoform (E6*I) compared to full-length E6 (E6FL), is critical for aggressive invasion. Introduction of splice switching oligonucleotides (SSOs) to inhibit E6FL splicing, effectively mitigated invasion. Mechanistic studies revealed that aggressive invasion occurs via E6*I-induced endocytosis of E-cadherin (ECAD) from the cell membrane, consistent with partial epithelial-to-mesenchymal transition (p-EMT). The clinical relevance of this mechanism was validated in patient cohorts where a reduced ratio of E6FL to all E6 splice variants was associated with high p-EMT signature, lower membrane:cell ECAD, and worse recurrence-free survival. Together, our findings show that low membrane:cell ECAD ratio in pre-treatment biopsies of HPV+ OPSCC, could stratify patients according to risk; patients with a low ratio may not be candidates for treatment de-intensification trials. Importantly, since ECAD detection is by immunohistochemistry, which is widely used even in diagnostic pathology laboratories with limited resources, membrane:cell ECAD ratio could be a clinically scalable biomarker. Targeting E6FL splicing with SSOs should be explored further as a logical strategy for therapeutic intervention in patients with HPV+ OPSCC.
Open AccessSplicing of HPV16 E6 promotes aggressive invasion in oropharyngeal cancer via endocytosis of E-cadherin
Human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC) is now the leading HPV+ cancer in the United States and United Kingdom. Despite high cure rates, a significant subset of patients have aggressive HPV+ OPSCC that recurs; deciphering the underlying mechanisms will identify biomarkers that delineate patient subgroups for personalized treatment. In a comprehensive investigation using complementary clinically-relevant models of HPV+ OPSCC, we demonstrated that elevated expression of a HPV16 E6 spliced isoform (E6*I) compared to full-length E6 (E6FL), is critical for aggressive invasion. Introduction of splice switching oligonucleotides (SSOs) to inhibit E6FL splicing, effectively mitigated invasion. Mechanistic studies revealed that aggressive invasion occurs via E6*I-induced endocytosis of E-cadherin (ECAD) from the cell membrane, consistent with partial epithelial-to-mesenchymal transition (p-EMT). The clinical relevance of this mechanism was validated in patient cohorts where a reduced ratio of E6FL to all E6 splice variants was associated with high p-EMT signature, lower membrane:cell ECAD, and worse recurrence-free survival. Together, our findings show that low membrane:cell ECAD ratio in pre-treatment biopsies of HPV+ OPSCC, could stratify patients according to risk; patients with a low ratio may not be candidates for treatment de-intensification trials. Importantly, since ECAD detection is by immunohistochemistry, which is widely used even in diagnostic pathology laboratories with limited resources, membrane:cell ECAD ratio could be a clinically scalable biomarker. Targeting E6FL splicing with SSOs should be explored further as a logical strategy for therapeutic intervention in patients with HPV+ OPSCC.
- Open Access
- 10 March 2022
- Published by Springer Nature in Cellular Oncology
- Vol. 45 (2) , 241-256
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
Purpose: Galanin receptor 2 (GALR2) plays a significant role in the progression of head and neck squamous cell carcinomas (HNSCC). Since there is virtually no information on immunomodulation mediated by its ligand in the tumor microenvironment, we assessed the effects of galanin on peripheral blood mononuclear cells (PBMCs). Methods: After verification of GALR2 expression and it activity in PBMCs we evaluated the effect of galanin and conditioned media from HNSCC cell lines silenced for galanin or antibody-depleted, on proliferation, apoptosis, cytokine expression and activation/differentiation of immune cells. Results: We found that galanin alone and as a component of the HNSCC secretome decreased HNSCC cell proliferation and expression of pro-inflammatory cytokines (IFNγ, IL-12, IL-17A, IL-1α, IL-6 and TNF-α), whilst increasing apoptosis and expression of pro-tumoral cytokines/growth factors (IL-10, IL-4, PDGF and GM-CSF). T cell activation (using CD69 as activation marker) and anti-tumoral phenotypes in CD4+ T cells (Th1 and Th17) were found to be suppressed. In vivo, tumor growth was found to be increased in the presence of galanin-stimulated PBMCs. Data from The Cancer Genome Atlas (TCGA) revealed that high expression of galanin was associated with a reduced overall survival of patients with HNSCC. Conclusion: Our data indicate that galanin secreted by HNSCC cells exhibits immune-suppressive and pro-tumoral effects.
- 10 March 2022
- Published by Springer Nature in Cellular Oncology
- Vol. 45 (2) , 241-256
Open AccessGalanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
Purpose: Galanin receptor 2 (GALR2) plays a significant role in the progression of head and neck squamous cell carcinomas (HNSCC). Since there is virtually no information on immunomodulation mediated by its ligand in the tumor microenvironment, we assessed the effects of galanin on peripheral blood mononuclear cells (PBMCs). Methods: After verification of GALR2 expression and it activity in PBMCs we evaluated the effect of galanin and conditioned media from HNSCC cell lines silenced for galanin or antibody-depleted, on proliferation, apoptosis, cytokine expression and activation/differentiation of immune cells. Results: We found that galanin alone and as a component of the HNSCC secretome decreased HNSCC cell proliferation and expression of pro-inflammatory cytokines (IFNγ, IL-12, IL-17A, IL-1α, IL-6 and TNF-α), whilst increasing apoptosis and expression of pro-tumoral cytokines/growth factors (IL-10, IL-4, PDGF and GM-CSF). T cell activation (using CD69 as activation marker) and anti-tumoral phenotypes in CD4+ T cells (Th1 and Th17) were found to be suppressed. In vivo, tumor growth was found to be increased in the presence of galanin-stimulated PBMCs. Data from The Cancer Genome Atlas (TCGA) revealed that high expression of galanin was associated with a reduced overall survival of patients with HNSCC. Conclusion: Our data indicate that galanin secreted by HNSCC cells exhibits immune-suppressive and pro-tumoral effects.
- Open Access
- 9 April 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Squamous cell carcinoma subverts adjacent histologically normal epithelium to promote lateral invasion
Recurrent and new tumors, attributed in part to lateral invasion, are frequent in squamous cell carcinomas and lead to poor survival. We identified a mechanism by which cancer subverts adjacent histologically normal epithelium to enable small clusters of cancer cells to burrow undetected under adjacent histologically normal epithelium. We show that suppression of DMBT1 within cancer promotes aggressive invasion and metastasis in vivo and is associated with metastasis in patients. Cancer cells via TGFβ1 and TNFα also suppress DMBT1 in adjacent histologically normal epithelium, thereby subverting it to promote invasion of a small population of tumor cells. The sufficiency of DMBT1 in this process is demonstrated by significantly higher satellite tumor nests in Dmbt1−/− compared with wild-type mice. Moreover, in patients, invasion of small tumor nests under adjacent histologically normal epithelium is associated with increased risk for recurrence and shorter disease-free survival. This study demonstrates a crucial role of adjacent histologically normal epithelium in invasion and its important role in the tumor microenvironment and opens new possibilities for therapeutic strategies that reduce tumor recurrence.
- 9 April 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Open AccessSquamous cell carcinoma subverts adjacent histologically normal epithelium to promote lateral invasion
Recurrent and new tumors, attributed in part to lateral invasion, are frequent in squamous cell carcinomas and lead to poor survival. We identified a mechanism by which cancer subverts adjacent histologically normal epithelium to enable small clusters of cancer cells to burrow undetected under adjacent histologically normal epithelium. We show that suppression of DMBT1 within cancer promotes aggressive invasion and metastasis in vivo and is associated with metastasis in patients. Cancer cells via TGFβ1 and TNFα also suppress DMBT1 in adjacent histologically normal epithelium, thereby subverting it to promote invasion of a small population of tumor cells. The sufficiency of DMBT1 in this process is demonstrated by significantly higher satellite tumor nests in Dmbt1−/− compared with wild-type mice. Moreover, in patients, invasion of small tumor nests under adjacent histologically normal epithelium is associated with increased risk for recurrence and shorter disease-free survival. This study demonstrates a crucial role of adjacent histologically normal epithelium in invasion and its important role in the tumor microenvironment and opens new possibilities for therapeutic strategies that reduce tumor recurrence.
- 14 June 2020
- Published by Wiley in International Endodontic Journal
- Vol. 53 (9) , 1264-1274
Effects of octenidine applied alone or mixed with sodium hypochlorite on eukaryotic cells
Aim: To assess the effects of octenidine dihydrochloride (OCT) on eukaryotic cells and the cytotoxicity of OCT associated with sodium hypochlorite – NaOCl (NaOCl/OCT).Methodology: L929 fibroblasts and human osteoblast‐like cells (Saos‐2) were exposed to 0.1% OCT, 2% CHX, 2.5% NaOCl, 5.25% NaOCl and mixtures of 5.25% NaOCl and 0.1% OCT (NaOCl/OCT) at 90 : 10, 80 : 20 and 50 : 50 ratios. Cell viability was assessed by methyl‐thiazol‐tetrazolium (MTT) and neutral red (NR) assays; type of cell death, by flow cytometry; cytoskeleton, by actin and α‐tubulin fluorescence; and alkaline phosphatase (ALP) activity, by thymolphthalein release. The data were analysed by two‐way ANOVA and Bonferroni tests (α = 0.05).Results: MTT and NR assays revealed that 0.1% OCT had the lowest cytotoxicity (P < 0.05), followed by 2% CHX (P < 0.05). The 2.5% NaOCl, NaOCl/OCT 80 : 20 and NaOCl/OCT 50 : 50 solutions had intermediate cytotoxicity. NaOCl 5.25% and NaOCl/OCT 90 : 10 had the highest cytotoxicity (P < 0.05). The OCT group had a higher percentage of viable cells than the NaOCl and CHX groups (P < 0.05), and induced apoptosis at higher doses. The cytoskeleton alterations were observed at 0.12%, 0.6% and 2.02% for the NaOCl, CHX and OCT groups, respectively. The solutions did not induce ALP activity.Conclusion: Octenidine dihydrochloride was less cytotoxic, induced apoptosis at higher doses, caused few changes in the cytoskeleton and did not induce alkaline phosphatase activity. In addition, octenidine dihydrochloride reduced the cytotoxicity of 5.25% NaOCl when combined at 20 and 50%.
- 14 June 2020
- Published by Wiley in International Endodontic Journal
- Vol. 53 (9) , 1264-1274
Effects of octenidine applied alone or mixed with sodium hypochlorite on eukaryotic cells
Aim: To assess the effects of octenidine dihydrochloride (OCT) on eukaryotic cells and the cytotoxicity of OCT associated with sodium hypochlorite – NaOCl (NaOCl/OCT).Methodology: L929 fibroblasts and human osteoblast‐like cells (Saos‐2) were exposed to 0.1% OCT, 2% CHX, 2.5% NaOCl, 5.25% NaOCl and mixtures of 5.25% NaOCl and 0.1% OCT (NaOCl/OCT) at 90 : 10, 80 : 20 and 50 : 50 ratios. Cell viability was assessed by methyl‐thiazol‐tetrazolium (MTT) and neutral red (NR) assays; type of cell death, by flow cytometry; cytoskeleton, by actin and α‐tubulin fluorescence; and alkaline phosphatase (ALP) activity, by thymolphthalein release. The data were analysed by two‐way ANOVA and Bonferroni tests (α = 0.05).Results: MTT and NR assays revealed that 0.1% OCT had the lowest cytotoxicity (P < 0.05), followed by 2% CHX (P < 0.05). The 2.5% NaOCl, NaOCl/OCT 80 : 20 and NaOCl/OCT 50 : 50 solutions had intermediate cytotoxicity. NaOCl 5.25% and NaOCl/OCT 90 : 10 had the highest cytotoxicity (P < 0.05). The OCT group had a higher percentage of viable cells than the NaOCl and CHX groups (P < 0.05), and induced apoptosis at higher doses. The cytoskeleton alterations were observed at 0.12%, 0.6% and 2.02% for the NaOCl, CHX and OCT groups, respectively. The solutions did not induce ALP activity.Conclusion: Octenidine dihydrochloride was less cytotoxic, induced apoptosis at higher doses, caused few changes in the cytoskeleton and did not induce alkaline phosphatase activity. In addition, octenidine dihydrochloride reduced the cytotoxicity of 5.25% NaOCl when combined at 20 and 50%.
- 1 November 2019
- Published by Elsevier in Archives of Oral Biology
- Vol. 107, 104508
The ATC/TTC haplotype in the Interleukin 8 gene in response to Gram-negative bacteria: A pilot study
- 1 November 2019
- Published by Elsevier in Archives of Oral Biology
- Vol. 107, 104508
The ATC/TTC haplotype in the Interleukin 8 gene in response to Gram-negative bacteria: A pilot study
- 29 November 2018
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 23 (8) , 3297-3306
Systemic administration of curcumin or piperine enhances the periodontal repair: a preliminary study in rats
Studies have documented the anti-inflammatory effects of spices, which may be related to treatment of chronic diseases. The purpose of this study was to evaluate the influence of curcumin and piperine and their association on experimental periodontal repair in rats.
- 29 November 2018
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 23 (8) , 3297-3306
Systemic administration of curcumin or piperine enhances the periodontal repair: a preliminary study in rats
Studies have documented the anti-inflammatory effects of spices, which may be related to treatment of chronic diseases. The purpose of this study was to evaluate the influence of curcumin and piperine and their association on experimental periodontal repair in rats.
- 1 November 2018
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 76 (11) , 2331.e1-2331.e10
Use of a Non-Crosslinked Collagen Membrane During Guided Bone Regeneration Does Not Interfere With the Bone Regenerative Capacity of the Periosteum
- 1 November 2018
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 76 (11) , 2331.e1-2331.e10
Use of a Non-Crosslinked Collagen Membrane During Guided Bone Regeneration Does Not Interfere With the Bone Regenerative Capacity of the Periosteum
- 13 January 2018
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 50 (6) , 651-660
Effect of low‐level laser therapy on the healing of sites grafted with coagulum, deproteinized bovine bone, and biphasic ceramic made of hydroxyapatite and β‐tricalcium phosphate. In vivo study in rats
Objective: The aim of this study was to evaluate the effect of low‐level laser therapy (LLLT) on the healing of biomaterial graft areas (i.e., coagulum, deproteinized bovine bone, and biphasic ceramics comprising hydroxyapatite and β‐tricalcium phosphate).Material and Methods: Ninety rats were divided into two groups according to laser irradiation use (λ 808 nm, 100 mW, φ ∼600 μm, seven sessions with 28 J of irradiation dose in total): a laser group and a control group. Each of these groups was divided into three subgroups of 15 animals each according to the type of biomaterial used: Coagulum (COA), deproteinized bovine bone (DBB), and hydroxyapatite/β‐tricalcium phosphate (HA/βTCP). Biomaterials were inserted into Teflon domes, and these domes were grafted to the lateral aspect of the mandibular branch of the rats. The animals were sacrificed after 30, 60, and 90 days. Scarring patterns were evaluated by microtomography and histometry. The expression levels of BMP2, osteocalcin (OCN), and alkaline phosphatase (ALP) were evaluated by immunohistochemistry. The mRNA expression levels of ALP, BMP2, Jagged1, Osterix, Runx2, and TGFβ1 were determined by RT‐qPCR.Results: The animals treated with LLLT exhibited increased mineralized tissues and bone, particularly after 90 days. These increases were associated with increased BMP2, OCN, and ALP protein expression and ALP, BMP2, and Jagged1 mRNA expression.Conclusion: LLLT improved the osteoconductive potential of DBB and HA/βTCP grafts and bone formation in ungrafted areas. Lasers Surg. Med. 50:651–660, 2018.
- 13 January 2018
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 50 (6) , 651-660
Effect of low‐level laser therapy on the healing of sites grafted with coagulum, deproteinized bovine bone, and biphasic ceramic made of hydroxyapatite and β‐tricalcium phosphate. In vivo study in rats
Objective: The aim of this study was to evaluate the effect of low‐level laser therapy (LLLT) on the healing of biomaterial graft areas (i.e., coagulum, deproteinized bovine bone, and biphasic ceramics comprising hydroxyapatite and β‐tricalcium phosphate).Material and Methods: Ninety rats were divided into two groups according to laser irradiation use (λ 808 nm, 100 mW, φ ∼600 μm, seven sessions with 28 J of irradiation dose in total): a laser group and a control group. Each of these groups was divided into three subgroups of 15 animals each according to the type of biomaterial used: Coagulum (COA), deproteinized bovine bone (DBB), and hydroxyapatite/β‐tricalcium phosphate (HA/βTCP). Biomaterials were inserted into Teflon domes, and these domes were grafted to the lateral aspect of the mandibular branch of the rats. The animals were sacrificed after 30, 60, and 90 days. Scarring patterns were evaluated by microtomography and histometry. The expression levels of BMP2, osteocalcin (OCN), and alkaline phosphatase (ALP) were evaluated by immunohistochemistry. The mRNA expression levels of ALP, BMP2, Jagged1, Osterix, Runx2, and TGFβ1 were determined by RT‐qPCR.Results: The animals treated with LLLT exhibited increased mineralized tissues and bone, particularly after 90 days. These increases were associated with increased BMP2, OCN, and ALP protein expression and ALP, BMP2, and Jagged1 mRNA expression.Conclusion: LLLT improved the osteoconductive potential of DBB and HA/βTCP grafts and bone formation in ungrafted areas. Lasers Surg. Med. 50:651–660, 2018.
- Open Access
- 9 October 2017
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 31, e75
Suppressor of cytokine signaling 1 expression during LPS-induced inflammation and bone loss in rats
This study aimed to characterize the dynamics of suppressor of cytokine signaling (SOCS1) expression in a rat model of lipopolysaccharide-induced periodontitis. Wistar rats in the experimental groups were injected three times/week with LPS from Escherichia coli on the palatal aspect of the first molars, and control animals were injected with vehicle (phosphate-buffered saline). Animals were sacrificed 7, 15, and 30 days after the first injection to analyze inflammation (stereometric analysis), bone loss (macroscopic analysis), gene expression (qRT-PCR), and protein expression/activation (Western blotting). The severity of inflammation and bone loss associated with LPS-induced periodontitis increased from day 7 to day 15, and it was sustained through day 30. Significant (p < 0.05) increases in SOCS1, RANKL, OPG, and IFN-γ gene expression were observed in the experimental group versus the control group at day 15. SOCS1 protein expression and STAT1 and NF-κB activation were increased throughout the 30-day experimental period. Gingival tissues affected by experimental periodontitis express SOCS1, indicating that this protein may potentially downregulate signaling events involved in inflammatory reactions and bone loss and thus may play a relevant role in the development and progression of periodontal disease.
- 9 October 2017
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 31, e75
Open AccessSuppressor of cytokine signaling 1 expression during LPS-induced inflammation and bone loss in rats
This study aimed to characterize the dynamics of suppressor of cytokine signaling (SOCS1) expression in a rat model of lipopolysaccharide-induced periodontitis. Wistar rats in the experimental groups were injected three times/week with LPS from Escherichia coli on the palatal aspect of the first molars, and control animals were injected with vehicle (phosphate-buffered saline). Animals were sacrificed 7, 15, and 30 days after the first injection to analyze inflammation (stereometric analysis), bone loss (macroscopic analysis), gene expression (qRT-PCR), and protein expression/activation (Western blotting). The severity of inflammation and bone loss associated with LPS-induced periodontitis increased from day 7 to day 15, and it was sustained through day 30. Significant (p < 0.05) increases in SOCS1, RANKL, OPG, and IFN-γ gene expression were observed in the experimental group versus the control group at day 15. SOCS1 protein expression and STAT1 and NF-κB activation were increased throughout the 30-day experimental period. Gingival tissues affected by experimental periodontitis express SOCS1, indicating that this protein may potentially downregulate signaling events involved in inflammatory reactions and bone loss and thus may play a relevant role in the development and progression of periodontal disease.